Etirinotecan pegol
Etirinotecan pegol Uses, Dosage, Side Effects, Food Interaction and all others data.
Etirinotecan pegol is under investigation in clinical trial NCT01663012 (Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma).
| Trade Name | Etirinotecan pegol |
| Generic | Etirinotecan pegol |
| Etirinotecan pegol Other Names | Etirinotecan pegol |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Etirinotecan pegol
